Video Shorts

Comparing Mechanisms of Action for BTK Degraders and Inhibitors

Highlighting a Phase 3 Trial of Ozuriftamab Vedotin in HPV-Associated OPSCC

Individualizing Efforts to Lower Recurrence Risk in Breast Cancer

Unpacking Data for Shorter Venetoclax Schedules in AML

Highlighting Radioligand Therapies in GEP-NETs

Emphasizing the Importance of Biomarkers in Head and Neck Cancer

Spotlighting the Efficacy and Safety of Atebimetinib-Based Therapy in Pancreatic Cancer

How Does Optune Pax Work in Pancreatic Cancer?

Highlighting the Efficacy of Daraxonrasib in Pancreatic Cancer

Exploring Unmet Needs in Head and Neck Cancer

What Is the Mechanism of Action of the Newly Approved Daraxonrasib for PDAC?

What Are the Next Steps for Darlifarnib Plus Cabozantinib in RCC?

Predicting How Today's FDA Approval of Zanidatamab Will Affect Gastric Cancer Care

What Does the RASolute 302 Trial Mean for Pancreatic Cancer Care?

What Does the Future Look Like for RAS-Targeted Therapies in Pancreatic Cancer?

Highlighting the Efficacy of Tucatinib Plus Trastuzumab and Pertuzumab in HER2+ Breast Cancer

Maurie Markman, MD, Talks AI in Cancer Care

Unpacking FIT-001 Data in RCC

Highlighting the Importance of Proactive Breast Cancer Care

Golcadomide Plus Rituximab Drives Durable Responses in R/R Follicular Lymphoma

Can AI Help Cure Cancer?

Why the TKI May Stay On at Next Line in EGFR-Mutated NSCLC

Joshua Richter, MD, Answers Rahul Banerjee, MD, FACP

KRASCENDO 170 Data With Divarasib and Pembrolizumab in Lung Cancer

Joshua Richter, MD, Discusses Multiple Myeloma Vaccines

Phase 1 Efficacy Data With INCB161734 in Pancreatic Cancer

Investigating Golcadomide in R/R Follicular Lymphoma

Has Balazs Halmos, MD, ever met his celebrity look alike?

Spotlighting the lidERA Trial in Breast Cancer

Exploring the Use of Proton Therapy in Head and Neck Cancer